Rachel E. Lill

1.1k total citations
17 papers, 868 citations indexed

About

Rachel E. Lill is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Rachel E. Lill has authored 17 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 13 papers in Pharmacology and 9 papers in Molecular Biology. Recurrent topics in Rachel E. Lill's work include Microbial Natural Products and Biosynthesis (13 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Cancer therapeutics and mechanisms (4 papers). Rachel E. Lill is often cited by papers focused on Microbial Natural Products and Biosynthesis (13 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Cancer therapeutics and mechanisms (4 papers). Rachel E. Lill collaborates with scholars based in United Kingdom, Germany and New Zealand. Rachel E. Lill's co-authors include Peter F. Leadlay, John W. Blunt, Murray H. G. Munro, Barrie Wilkinson, Sarah J. H. Hickford, Christopher N. Battershill, Sabine Gaisser, Alan Duckworth, Eric J. Dumdei and Shangxiao Li and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and Molecular Microbiology.

In The Last Decade

Rachel E. Lill

17 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel E. Lill United Kingdom 15 547 430 341 302 62 17 868
Arlette Longeon France 18 249 0.5× 312 0.7× 361 1.1× 312 1.0× 42 0.7× 29 935
Thomas L. Simmons United States 9 428 0.8× 418 1.0× 438 1.3× 180 0.6× 30 0.5× 12 988
Taro Amagata United States 18 469 0.9× 265 0.6× 410 1.2× 321 1.1× 48 0.8× 22 843
Dedra Harmody United States 15 296 0.5× 266 0.6× 364 1.1× 341 1.1× 26 0.4× 17 791
Kaneo Kanoh Japan 21 418 0.8× 533 1.2× 298 0.9× 308 1.0× 91 1.5× 34 1.1k
Birgit Ohlendorf Germany 15 489 0.9× 221 0.5× 308 0.9× 161 0.5× 100 1.6× 19 702
Haiyin He United States 23 753 1.4× 633 1.5× 419 1.2× 583 1.9× 140 2.3× 45 1.5k
Keiichiro Motohashi Japan 18 502 0.9× 297 0.7× 326 1.0× 145 0.5× 58 0.9× 29 675
Taiko Oda Japan 18 171 0.3× 262 0.6× 219 0.6× 299 1.0× 50 0.8× 66 849
O. F. Smetanina Russia 17 533 1.0× 198 0.5× 423 1.2× 144 0.5× 64 1.0× 49 749

Countries citing papers authored by Rachel E. Lill

Since Specialization
Citations

This map shows the geographic impact of Rachel E. Lill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Lill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Lill more than expected).

Fields of papers citing papers by Rachel E. Lill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel E. Lill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Lill. The network helps show where Rachel E. Lill may publish in the future.

Co-authorship network of co-authors of Rachel E. Lill

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel E. Lill. A scholar is included among the top collaborators of Rachel E. Lill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel E. Lill. Rachel E. Lill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gregory, Matthew A., Steven G. Kendrew, Nigel J. Coates, et al.. (2012). Structure guided design of improved anti-proliferative rapalogs through biosynthetic medicinal chemistry. Chemical Science. 4(3). 1046–1052. 13 indexed citations
2.
Schell, Ursula, Stephen Haydock, Isabelle Carletti, et al.. (2008). Engineered biosynthesis of hybrid macrolide polyketides containing d-angolosamine and d-mycaminose moieties. Organic & Biomolecular Chemistry. 6(18). 3315–3315. 26 indexed citations
3.
Gregory, Matthew A., Hui Hong, Rachel E. Lill, et al.. (2006). Rapamycin biosynthesis: elucidation of gene product function. Organic & Biomolecular Chemistry. 4(19). 3565–3565. 40 indexed citations
4.
Lill, Rachel E., Barrie Wilkinson, Rose Sheridan, et al.. (2006). Engineering of the Spinosyn PKS:  Directing Starter Unit Incorporation. Journal of Natural Products. 69(12). 1702–1710. 40 indexed citations
5.
Gregory, Matthew A., Hrvoje Petković, Rachel E. Lill, et al.. (2005). Mutasynthesis of Rapamycin Analogues through the Manipulation of a Gene Governing Starter Unit Biosynthesis. Angewandte Chemie International Edition. 44(30). 4757–4760. 84 indexed citations
6.
Gregory, Matthew A., Hrvoje Petković, Rachel E. Lill, et al.. (2005). Mutasynthesis of Rapamycin Analogues through the Manipulation of a Gene Governing Starter Unit Biosynthesis. Angewandte Chemie. 117(30). 4835–4838. 16 indexed citations
7.
Gregory, Matthew A., Sabine Gaisser, Rachel E. Lill, et al.. (2004). Isolation and Characterization of Pre‐rapamycin, the First Macrocyclic Intermediate in the Biosynthesis of the Immunosuppressant Rapamycin by S. hygroscopicus. Angewandte Chemie International Edition. 43(19). 2551–2553. 36 indexed citations
8.
Gregory, Matthew A., Sabine Gaisser, Rachel E. Lill, et al.. (2004). Isolation and Characterization of Pre‐rapamycin, the First Macrocyclic Intermediate in the Biosynthesis of the Immunosuppressant Rapamycin by S. hygroscopicus. Angewandte Chemie. 116(19). 2605–2607. 2 indexed citations
9.
Petković, Hrvoje, Steven G. Kendrew, Barrie Wilkinson, et al.. (2003). Active-site residue, domain and module swaps in modular polyketide synthases. Journal of Industrial Microbiology & Biotechnology. 30(8). 489–494. 105 indexed citations
10.
Petković, Hrvoje, Rachel E. Lill, Rose Sheridan, et al.. (2003). A Novel Erythromycin, 6-Desmethyl Erythromycin D, Made by Substituting an Acyltransferase Domain of the Erythromycin Polyketide Synthase. The Journal of Antibiotics. 56(6). 543–551. 32 indexed citations
11.
Gaisser, Sabine, Laurenz Kellenberger, Alison J. Weston, et al.. (2003). Direct production of ivermectin-like drugs after domain exchange in the avermectin polyketide synthase of Streptomyces avermitilis ATCC31272. Organic & Biomolecular Chemistry. 1(16). 2840–2840. 35 indexed citations
13.
Gaisser, Sabine, Rachel E. Lill, James Staunton, et al.. (2002). Parallel pathways for oxidation of 14‐membered polyketide macrolactones in Saccharopolyspora erythraea. Molecular Microbiology. 44(3). 771–781. 34 indexed citations
14.
Gaisser, Sabine, et al.. (2001). New erythromycin derivatives from Saccharopolyspora erythraea using sugar O‐methyltransferases from the spinosyn biosynthetic gene cluster. Molecular Microbiology. 41(5). 1223–1231. 27 indexed citations
15.
Munro, Murray H. G., John W. Blunt, Eric J. Dumdei, et al.. (1999). The discovery and development of marine compounds with pharmaceutical potential. Journal of Biotechnology. 70(1-3). 15–25. 272 indexed citations
16.
Litaudon, Marc, Sarah J. H. Hickford, Rachel E. Lill, et al.. (1997). Antitumor Polyether Macrolides:  New and Hemisynthetic Halichondrins from the New Zealand Deep-Water Sponge Lissodendoryx sp.. The Journal of Organic Chemistry. 62(6). 1868–1871. 45 indexed citations
17.
Lill, Rachel E., et al.. (1995). Studies on the Biosynthesis of Discorhabdin B in the New Zealand Sponge Latrunculia sp. B. Journal of Natural Products. 58(2). 306–311. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026